Research Summary Bundle of two separate vials BPC-157 20mg and TB-500 20mg
Conventional copper-modulating therapies, including chelators (e.g., TTM and TETA) and the ionophore elesclomol, are fundamentally limited by their lack of specificity, which constrains their clinical utility and leads to significant adverse effects
Regulatory framing in the EU and US None of the three peptides in the Glow Stack are approved drug substances for human therapeutic use in the European Union or the United States
This compound has gained attention for several biological properties: Wound healing and tissue regeneration Stimulation of collagen production Anti-inflammatory effects Antioxidant properties Promotion of blood vessel formation Due to these properties, GHK-Cu is used in: Skincare products, particularly anti-aging formulations Hair growth treatments Wound healing applications Research suggests it works by activating specific genes related to healing and attracting immune cells to injury sites
GHK-Cu is a copper-zinc dependent peptide, so adequate zinc levels may support optimal copper peptide utilisation
This is discussed in our blog: Trophic Support for Cognitive Impairment Key Takeaways Brain fog is common but its aetiology is unclear and may be due to multiple dysfunctions Studies on long covid have allowed us to understand further the impacts on cognitive function and mechanisms by which brain fog can occur